169 related articles for article (PubMed ID: 25374060)
1. Downregulation of CPE regulates cell proliferation and chemosensitivity in pancreatic cancer.
Liu A; Shao C; Jin G; Liu R; Hao J; Shao Z; Liu Q; Hu X
Tumour Biol; 2014 Dec; 35(12):12459-65. PubMed ID: 25374060
[TBL] [Abstract][Full Text] [Related]
2. Silencing of Carboxypeptidase E expression inhibits proliferation and invasion of Panc-1 pancreatic cancer cells.
Lou H; Loh YP
F1000Res; 2021; 10():489. PubMed ID: 35528956
[No Abstract] [Full Text] [Related]
3. Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer.
Liang XH; Li LL; Wu GG; Xie YC; Zhang GX; Chen W; Yang HF; Liu QL; Li WH; He WG; Huang YN; Zeng XC
BMC Cancer; 2013 Sep; 13():412. PubMed ID: 24006921
[TBL] [Abstract][Full Text] [Related]
4. Carboxypeptidase E-∆N Promotes Proliferation and Invasion of Pancreatic Cancer Cells via Upregulation of CXCR2 Gene Expression.
Hareendran S; Yang X; Lou H; Xiao L; Loh YP
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731578
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-100 regulates pancreatic cancer cells growth and sensitivity to chemotherapy through targeting FGFR3.
Li Z; Li X; Yu C; Wang M; Peng F; Xiao J; Tian R; Jiang J; Sun C
Tumour Biol; 2014 Dec; 35(12):11751-9. PubMed ID: 25344675
[TBL] [Abstract][Full Text] [Related]
6. Carboxypeptidase E down-regulation regulates transcriptional and epigenetic profiles in pancreatic cancer cell line: A network analysis.
Bai Z; Feng M; Du Y; Cong L; Cheng Y
Cancer Biomark; 2020; 29(1):79-88. PubMed ID: 32675394
[TBL] [Abstract][Full Text] [Related]
7. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
8. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
Melisi D; Niu J; Chang Z; Xia Q; Peng B; Ishiyama S; Evans DB; Chiao PJ
Mol Cancer Res; 2009 May; 7(5):624-33. PubMed ID: 19435817
[TBL] [Abstract][Full Text] [Related]
9. Overexpressing PRMT1 Inhibits Proliferation and Invasion in Pancreatic Cancer by Inverse Correlation of ZEB1.
Lin Z; Chen Y; Lin Z; Chen C; Dong Y
IUBMB Life; 2018 Oct; 70(10):1032-1039. PubMed ID: 30194893
[TBL] [Abstract][Full Text] [Related]
10. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
12. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo.
Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C
Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702
[TBL] [Abstract][Full Text] [Related]
13. HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3.
Hou X; Yang L; Wang K; Zhou Y; Li Q; Kong F; Liu X; He J
Cancer Med; 2021 Jan; 10(1):350-364. PubMed ID: 33280236
[TBL] [Abstract][Full Text] [Related]
14. p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway.
Tyagi N; Bhardwaj A; Singh AP; McClellan S; Carter JE; Singh S
Oncotarget; 2014 Sep; 5(18):8778-89. PubMed ID: 25238288
[TBL] [Abstract][Full Text] [Related]
15. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
[No Abstract] [Full Text] [Related]
16. Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ.
Sato M; Nakanishi K; Haga S; Fujiyoshi M; Baba M; Mino K; ; Niwa H; Yokoo H; Umezawa K; Ohmiya Y; Kamiyama T; Todo S; Taketomi A; Ozaki M
Oncol Res; 2013; 21(6):333-43. PubMed ID: 25198663
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt/NF-κB signaling pathway.
Wang S; Gao Y
Int Immunopharmacol; 2021 Nov; 100():107990. PubMed ID: 34482266
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
20. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]